Dermatology
News
FDA accepts priority review of dupilumab for adolescent atopic dermatitis
Phase 3 study results of dupilumab in patients aged 12-17 years with atopic dermatitis were submitted to the agency.
Conference Coverage
Think barrier repair for acne patients
LAS VEGAS – Quality moisturization is a must for acne patients and has been shown to improve TEWL, normalize ceramides, and repair the microbiome...
Conference Coverage
AD update: New insight into pathogenesis, prevention, and treatments
LAS VEGAS – Filaggrin mutations appear to play a role in the development of AD, but not in a significant proportion of people with AD.
Conference Coverage
Topical treatment with retinoid/benzoyl peroxide combination reduced acne scars
PARIS –The acne treatment adapalene 0.3%/benzoyl peroxide 2.5% gel prevented new scar formation in a multicenter study.
Pediatric Dermatology Consult
What is your diagnosis?
Conference Coverage
Allergen of the year may be nearer than you think
MONTEREY, CALIF. – Keep an eye on topical antibiotics, fragrances, and preservatives too, dermatologist urges colleagues.
News
FDA approves omadacycline for pneumonia and skin infections
The tetracycline antibiotic was approved for CABP and acute bacterial skin and skin structure infections in adults.
From the Journals
Adalimumab safety profile similar in children and adults
The most common adverse events across indications were upper respiratory tract infection, nasopharyngitis, and headache.
News
FDA approves Seysara for treatment of moderate to severe acne
Conference Coverage
Dupilumab positive in phase 3 study for treating adolescent atopic dermatitis
PARIS – The study was the first-ever phase 3 trial of a biologic in a pediatric atopic dermatitis population.
Conference Coverage
Topical cyclosporine safely tamed atopic dermatitis in 4-week study
PARIS – Therapeutic benefits seen within first week.